Is CFRX or JEPQ a better dividend investment in 2026?

CFRX currently yields 4000.00% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: CFRX offers higher current income.

What is the dividend yield difference between CFRX and JEPQ?

CFRX has a forward dividend yield of 4000.00% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 3988.90 percentage points.

Home › Compare › CFRX vs JEPQ

CFRX vs JEPQ: Dividend Comparison 2026

CFRX yields 4000.00% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CFRX wins by $7175340620755.83M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CFRX

● Live price

4000.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7175340620755.87M

Annual income

$6,839,006,593,197,835,000.00

Full CFRX calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — CFRX vs JEPQ

📍 CFRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CFRX	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CFRX + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CFRX pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFRX

Annual income on $10K today (after 15% tax)

$340,000.00/yr

After 10yr DRIP, annual income (after tax)

$5,813,155,604,218,160,000.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, CFRX beats the other by $5,813,155,604,218,158,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFRX + JEPQ for your $10,000?

CFRX: 50%JEPQ: 50%

100% JEPQ50/50100% CFRX

Portfolio after 10yr

$3587670310377.96M

Annual income

$3,419,503,296,598,918,700.00/yr

Blended yield

95.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CFRX right now

CFRX

Analyst Ratings

Strong

Buy

Hold

Consensus: Hold

Altman Z

-60.9

Piotroski

1/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFRX buys

JEPQ buys

No recent congressional trades found for CFRX or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCFRXJEPQ

Forward yield	4000.00% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7175340620755.87M ✓	$44.8K
Annual income after 10y	$6,839,006,593,197,835,000.00 ✓	$2,152.59
Total dividends collected	$7152397773804.84M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CFRX vs JEPQ ($10,000, DRIP)

Year	CFRX Portfolio	CFRX Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$410,700	$400,000.00	$11,930	$1,110.39	+$398.8K → CFRX
2	$15,792,720	$15,353,271.03	$14,133	$1,224.34	+$15.78M → CFRX
3	$568,657,142	$551,758,931.89	$16,632	$1,340.46	+$568.64M → CFRX
4	$19,176,207,860	$18,567,744,718.20	$19,454	$1,457.97	+$19176.19M → CFRX
5	$605,696,028,890	$585,177,486,479.73	$22,626	$1,576.08	+$605696.01M → CFRX
6	$17,922,210,653,594	$17,274,115,902,681.27	$26,175	$1,694.09	+$17922210.63M → CFRX
7	$496,869,793,504,300	$477,693,028,104,954.00	$30,133	$1,811.32	+$496869793.47M → CFRX
8	$12,908,672,105,251,704	$12,377,021,426,202,104.00	$34,531	$1,927.17	+$12908672105.22M → CFRX
9	$314,330,866,876,668,540	$300,518,587,724,049,200.00	$39,403	$2,041.08	+$314330866876.63M → CFRX
10	$7,175,340,620,755,871,000	$6,839,006,593,197,835,000.00	$44,787	$2,152.59	+$7175340620755.83M → CFRX

CFRX vs JEPQ: Complete Analysis 2026

CFRX — Stock

ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also initiated an expanded access program to provide Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York.

Full CFRX Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this CFRX vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFRX vs SCHD CFRX vs JEPI CFRX vs O CFRX vs KO CFRX vs MAIN CFRX vs XYLD CFRX vs QYLD CFRX vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.